Position in RVMD
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$92,232,216
+$42,948,250 QoQ
Shares Held
492,483
-2.8% QoQ
Ownership
0.230%
of shares outstanding
% of Portfolio
5.62%
of 13F equity value
Holder Rank
#65
of 687 holders
Holding Since
Sep 2021
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RVMD Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MPM BIOIMPACT LLC holds $1,463,416,616 across 34 Biotechnology names. RVMD ranks #3 (6.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CGEM |
Cullinan Therapeutics, Inc.
|
9,731,341 | $177,207,719 | |
| 2 | AKTS |
Aktis Oncology, Inc.
|
4,835,872 | $155,860,154 | |
| 3 | RVMD |
Revolution Medicines, Inc.
This page
|
492,483 | $92,232,216 | |
| 4 | CORT |
Corcept Therapeutics Inc
|
771,028 | $67,040,884 | |
| 5 | EWTX |
Edgewise Therapeutics, Inc.
|
1,620,780 | $65,852,291 | |
| 6 | TVTX |
Travere Therapeutics, Inc.
|
1,122,731 | $63,782,348 | |
| 7 | DBVT |
DBV Technologies S.A.
|
3,666,284 | $60,127,057 | |
| 8 | TRVI |
Trevi Therapeutics, Inc.
|
3,073,577 | $57,322,211 |
All Filings in RVMD
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $92,232,216 | 492,483 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $49,283,966 | 506,776 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $40,276,774 | 505,672 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $14,744,217 | 315,722 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $11,615,412 | 315,722 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $11,212,054 | 317,083 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $13,726,355 | 313,817 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $13,214,581 | 291,391 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $11,231,458 | 289,396 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $8,805,783 | 273,217 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $7,841,341 | 273,408 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $7,567,933 | 273,408 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $7,313,664 | 273,408 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $5,350,496 | 247,022 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $3,550,204 | 149,043 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $2,879,928 | 146,041 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $2,846,339 | 146,041 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $3,725,505 | 146,041 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $3,675,851 | 146,041 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $4,126,500 | 150,000 | Shares | Sole | 2021-11-15 | |
| No filing history on record for this holder in this stock. | ||||||